Basic Information
Ark Bio is an end-to-end solution provider focused on early cancer detection. By leveraging advanced data science and proprietary miRNA testing technology, Ark Bio has developed non-invasive and cost-effective blood tests to detect early-stage cancer before clinical symptoms appear. The company has conducted extensive collaborations with top global medical research institutions and launched the largest miRNA clinical study in Asia, involving over 50,000 participants. Ark Bio is headquartered in Singapore, with R&D, manufacturing, and clinical diagnostics departments in China and the United States.